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Polyunsaturated fatty acid (PUFA), a key marker in breast cancer, is non-invasively quantifiable using 
multiple quantum coherence (MQC) magnetic resonance spectroscopy (MRs) at the expense of losing 
half of the signal. signal combination for phased array coils provides potential pathways to enhance the 
signal to noise ratio (sNR), with current algorithms developed for conventional brain MRs. since pUFA 
spectra and the biochemical environment in the breast deviate significantly from those in the brain, 
we set out to identify the optimal algorithm for pUFA in breast cancer. Combination algorithms were 
compared using PUFA spectra from 17 human breast tumour specimens, 15 healthy female volunteers, 
and 5 patients with breast cancer on a clinical 3 T MRI scanner. Adaptively Optimised Combination  
(AOC) yielded the maximum SNR improvement in specimens (median, 39.5%; interquartile range:  
35.5–53.2%, p < 0.05), volunteers (82.4 ± 37.4%, p < 0.001), and patients (median, 61%; range: 
34–105%, p < 0.05), while independent from voxel volume (rho = 0.125, p = 0.632), PUFA content 
(rho = 0.256, p = 0.320) or water/fat ratio (rho = 0.353, p = 0.165). Using AOC, acquisition in patients is 
1.5 times faster compared to non-noise decorrelated algorithms. Therefore, AOC is the most suitable 
current algorithm to improve sNR or accelerate the acquisition of pUFA MRs from breast in a clinical 
setting.
Breast cancer is the most prevalent form of cancer among women worldwide1, and polyunsaturated fatty acid 
(PUFA) is a key marker for treatment monitoring2. Although magnetic resonance spectroscopy (MRS) is a 
non-invasive approach for metabolite profiling3, PUFA measurement is not possible due to the overwhelming 
signals of monounsaturated fatty acid (MUFA) and water4. Multiple quantum coherence (MQC) MRS suppresses 
MUFA and water for accurate PUFA detection, but sacrifices half of the acquired signal4,5. Although PUFA is 
abundant in healthy female breast, its depletion is characteristic of rapid cell division in tumour6. Due to the low 
abundance of PUFA in tumour6 and further loss of half of the detected signal using MQC4, improvement in SNR 
is essential for accurate quantification in treatment monitoring, especially if small changes in PUFA concentration 
occur. In addition, the achieved SNR improvement can be utilised to reduce acquisition time. Therefore, it is crit-
ical to enhance the signal to noise ratio (SNR) of PUFA acquired using MQC MRS in patients with breast cancer.
The combination of signals acquired from phased array coils provides an effective approach for improving 
SNR7,8 with prior development focusing on conventional MRS in the brain (Table 1)9–20. Equal Weighting algo-
rithm derives the combined spectrum through summation of signals from all the coil elements after all signals 
are aligned in phase9. To account for the influence of coil sensitivities, the Signal Weighting algorithm weights 
each coil element with the amplitude of the reference peak received on the corresponding coil element after 
phase alignment12–14. In order to further account for the noise variations between different coil elements, the S/N 
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Weighting algorithm weights each coil element with the SNR of the reference peak15–17. Subsequently, the S/N2 
Weighting algorithm was introduced through weighting each coil element with the ratio of signal to noise square 
of the reference peak, and is the optimal algorithm for combination of signals containing purely uncorrelated 
noise9.
Since correlated noise presents during in vivo data acquisition10, algorithms employing noise decorrelation 
were developed10,18,21. Noise decorrelation combination (nd-comb) initially employs the Principal Component 
Analysis (PCA) to remove correlated noise before applying the S/N Weighting algorithm18,19. In contrast, 
Whitened Singular Value Decomposition (WSVD)21,22 applies the singular value decomposition23,24 on the 
noise-decorrelated data to derive the weighting. Hence, WSVD exploits the whole noise-decorrelated spec-
tra to estimate the weighting compared to the single reference peak used in nd-comb. Instead of eliminating 
the correlated noise as a preparation step, Adaptively Optimised Combination (AOC) algorithm derives the 
weighting from the amplitude of a reference peak (typically water) incorporating the inverted noise correlation 
matrix10.
Investigations on phased array combination algorithms have focused so far on conventional MRS in the 
brain9–20, with significant different spectral appearance and metabolite composition compared to breast. 
Furthermore, existing investigations were limited to phantoms and healthy volunteers, and hence confined to 
a narrow physiological variability raising the issue of their applicability in clinical setting. We therefore system-
atically examined current signal combination algorithms on PUFA spectra acquired using MQC MRS in breast 
tumours.
Results
Comparison of signal combination algorithms. Signal combination algorithms9,10,18,21 (Table 1) were 
implemented and evaluated with the study design shown in Fig. 1. PUFA spectra were acquired using MQC MRS 
from whole breast tumour specimens freshly excised from patients, healthy female volunteers and patients with 
breast cancer. The combination algorithms were compared using the SNR improvement of PUFA referenced to 
the SNR obtained from the Equal Weighting algorithm (defined as baseline SNR). Our results show that for breast 
tumour specimens, the SNR improvement from AOC (median: 39.5%, interquartile range: 35.5–53.2%) was sig-
nificantly higher than other algorithms (p < 0.05) (Table 2, Fig. 2a). WSVD gave negative SNR improvement for 
Algorithms Description
Equal Weighting Adding after aligning in phase
Signal Weighting Weighting based on Signal of reference peak
S/N Weighting Weighting based on Signal/Noise of reference peak
S/N2 Weighting Weighting based on Signal/Noise2 of reference peak
nd-comb 1. Noise decorrelation by PCA,2. Weighting the noise decorrelated data based on Signal/Noise of reference peak
WSVD
1. Noise decorrelation by PCA,
2. Weighting the noise decorrelated spectrum based on the first left singular vector obtained using the singular value 
decomposition of the noise decorrelated spectra
AOC Weighting based on Signal of reference peak (typically water) multiplied by the inverted noise correlation matrix
Table 1. Description of the existing signal combination algorithms. Table describes the calculation of the 
weighting coefficient for the linear combination algorithms of Equal Weighting, Signal Weighting, S/N 
Weighting, and S/N2 Weighting and the noise decorrelated algorithms of nd-comb, WSVD, and AOC. 
AOC = adaptively optimised combination. Nd-comb = noise decorrelation combination, PCA = Principal 
Component Analysis, WSVD = whitened singular value decomposition.
Figure 1. Study design. The algorithms of AOC, nd-comb, WSVD, S/N2 Weighting, S/N Weighting, and 
Signal Weighting were evaluated through PUFA spectra acquired from ex vivo and in vivo experiments. The 
Equal Weighting algorithm was used as a reference to calculate the SNR improvement for different algorithms. 
AOC = adaptively optimised combination. Nd-comb = noise decorrelation combination, WSVD = whitened 
singular value decomposition.
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5 out of 17 breast tumour specimens, when baseline SNR was below 7.5 showing dependency on baseline SNR 
and voxel volume (Supplementary Fig. S1). For spectra with baseline SNR higher than 7.5, AOC gave comparable 
SNR improvement to WSVD (Table 2). In healthy volunteers, SNR improvement from AOC (82.4 ± 37.4%) was 
significantly higher than other algorithms (p < 0.001) (Table 2, Fig. 2b). In patients, AOC yielded the highest 
average SNR improvement of 61% (34–105%) (median, range) (Table 2, Fig. 2c), which was significantly higher 
compared to each of the algorithms, apart from nd-comb (Wilcoxon signed-rank test on small sample size of 
N = 5). The AOC improvement was 24% (4–28%), 29% (4–35%), and 34% (5–43%) relative to S/N2 Weighting, 
S/N Weighting and Signal Weighting respectively. WSVD produced negative SNR improvement in 2 datasets 
acquired from healthy volunteers and 2 datasets from patients where contamination lipid signal was present, as 
shown in Fig. 3. AOC gave comparable SNR improvement to WSVD for healthy volunteers when spectra with 
negative SNR improvement were excluded (Table 2).
AoC is independent from biochemical environment and voxel volume. We examined whether 
the SNR improvement, derived from AOC as being the optimal algorithm, is dependent on experimental con-
ditions of PUFA content, voxel volume, and water/fat ratio. There was no significant correlation between the 
SNR improvement from AOC against PUFA content for breast tumour specimens (Fig. 4a) or healthy volunteers 
(Fig. 4b). The SNR improvement from AOC algorithm was independent from the voxel volume (Fig. 4c) and 
water/fat ratio in breast tumour specimens (Fig. 4d).
Acquisition time in breast cancer using AoC. We tested how much we can reduce the acquisition of 
PUFA spectra in patients if noise correlation is not ignored. Therefore, we examined how much we can reduce 
the scan time to achieve the same output SNR using AOC in comparison to S/N2 Weighting. We additionally 
compared AOC with Equal Weighting (baseline SNR). Our results show that using AOC, the number of repeated 
acquisitions for PUFA spectra (median, range) could be as low as 175 (117–185) or 71 (15–110) instead of 256 to 
achieve same output SNR as S/N2 Weighting and Equal Weighting respectively (Fig. 5, Supplementary Fig. S2a,b). 
Hence, PUFA acquisition time in patients could be reduced to 68% (46–72%) or to 28% (6–43%) of the original 
scan time compared to S/N2 Weighting and Equal Weighting respectively.
Discussion
In this work, we compared current algorithms for combining PUFA spectra acquired using MQC MRS on phased 
array coils in breast cancer. AOC yielded the highest SNR improvement in excised breast tumours, healthy vol-
unteers and patients. Moreover, AOC showed robustness against voxels with relatively low baseline SNR and was 
not affected by the presence of contamination lipid signal. AOC can be used for breast tumours with wide range 
of volumes, PUFA, water or fat contents, demonstrating the applicability in clinical settings.
AOC was the optimal algorithm consistently in both ex vivo and in vivo experiments. For ex vivo experiments, 
there was a clear difference in SNR improvement between the noise decorrelated algorithms (an average of 44% 
from AOC and nd-comb) and the linear algorithms (an average of 30% from S/N2 Weighting, S/N Weighting, and 
Signal Weighting). Among the linear algorithms, S/N2 Weighting had the best SNR improvement as predicted 
theoretically9 followed by S/N Weighting and Signal Weighting as shown in brain MRS9. WSVD gave a large 
variance of SNR improvement ranging from −100 to 77% dependent on the baseline SNR, since WSVD uses the 
PUFA spectra to estimate the weighting (reference spectra in AOC and nd-comb). A minimum baseline SNR (7.5 
in this study) is required for WSVD to accurately identify the PUFA peak (phase and amplitude) in order to yield 
comparable SNR improvement as other noise decorrelated algorithms. This is in agreement with the literature 
findings in brain MRS where WSVD was shown to give comparable results with other noise decorrelated algo-
rithms at high SNR levels but worse performance at low SNR11. AOC gave significantly higher SNR improvement 
Methods
Ex vivo experiments In vivo experiments
p-value
Breast tumour specimens (N = 17) Healthy volunteers (N = 15, 30 voxels) Patients (N = 5)
SNR SNR improvement % p-value SNR SNR improvement % p-value SNR SNR improvement %
Equal 12.5 (6.9–18.4) — — 37.0 ± 21.6 — — 9 (4–21) — —
Signal 14.2 (8.3–24.7) 24.8 (16.6–34.8) <0.001 49.1 ± 33.1 29.5 ± 19.5 <0.001 12 (5–24) 28 (13–53) 0.043
S/N 14.4 (8.3–25.6) 27.2 (17.7–38.3) <0.001 50.6 ± 33.3 34.2 ± 18.4 <0.001 12 (5–25) 30 (19–58) 0.043
S/N2 14.4 (8.3–26.0) 27.8 (17.9–40.8) 0.001 51.5 ± 33.3 37.4 ± 17.8 <0.001 12 (6–27) 29 (25–62) 0.043
WSVD 23.0 (13.1–32.2) 41.4 (26.1–53.6) 0.074 66.5 ± 39.6 81.3 ± 42.3 0.312 11 (7–22) 20 (−100–90) 0.043
nd-comb 16.7 (9.5–27.1) 37.7 (33.8–49.8) 0.039 64.9 ± 40.6 79.2 ± 36.1 <0.001 13 (7–33) 56 (35–101) 0.138
AOC 16.3 (9.6–27.3) 39.5 (35.5–53.2) — 65.9 ± 41.1 82.4 ± 37.4 — 13 (7–34) 61 (34–105) —
Table 2. SNR and SNR improvement for the ex vivo and in vivo experiments. Mean and interquartile range in 
parenthesis are shown for ex vivo experiments (non-normally distributed), mean and standard deviation are 
shown for healthy volunteers (normally distributed data), while median and range in parenthesis are shown 
for patients due to small sample size. P-value represents the comparison on SNR improvement between the 
different algorithms. Results are presented with AOC as a reference for comparison. For WSVD, SNR and SNR 
improvement were calculated after excluding data with negative SNR improvement from tumour specimens 
(N = 12) and healthy volunteers (N = 28). AOC = adaptively optimised combination. Nd-comb = noise 
decorrelation combination, WSVD = whitened singular value decomposition.
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compared to nd-comb, because nd-comb eliminates correlated noise before linear combination while AOC bal-
ances the signal against the overall noise10. For healthy volunteers, the difference in SNR improvement between 
the noise decorrelated algorithms and the linear algorithms was larger (up to 47%) due to higher noise correla-
tion found in vivo. WSVD was susceptible to the presence of contamination lipid signal (for 4 out of 30 data), as 
found in brain MRS acquired near the skull25 whilst comparable to AOC for data with no lipid contamination. 
In patients, the difference between noise decorrelated algorithms and the linear algorithms was 28%. WSVD was 
susceptible to the presence of contamination signal in two patients and the low baseline SNR in the remaining 
three patients. AOC gave significantly higher SNR improvement compared to each of the algorithms apart from 
nd-comb. However, caution should be practised in interpreting these findings due to the small sample size. Based 
on consistent results among the experiments, AOC is most likely to provide the maximal SNR improvement in 
patients without susceptibility to low baseline SNR or contamination signal.
We examined the relationship between AOC and experimental conditions, including PUFA content, voxel 
volume and water/fat ratio. There was no dependency of AOC performance on voxel volume, and hence SNR 
level, in agreement with simulated and acquired MRS in the brain11. There was also no dependency of AOC on 
PUFA content and water/fat ratio in tumour specimens nor on PUFA content in healthy volunteers. In contrast, 
WSVD showed dependency on baseline SNR as well as voxel volume, confirming the categorical difference shown 
in group analysis. Therefore, AOC is functional in a wide range of breast tumour sizes and PUFA, water or fat 
contents, making it the ideal choice for clinical applications.
AOC, although independent from biochemical environment and voxel size in our study, is affected by voxel 
location10. Voxels, centred on the tumour, were positioned at the isocentre in ex vivo experiments. However, 
positioning the voxels at the isocentre was not feasible for in vivo experiments, leading to a wider signal dis-
parity across coil elements, and in turn to a more pronounced SNR improvement, as shown in brain MRS 
studies9,10. The variability in SNR improvement observed in vivo was higher than ex vivo due to the varying 
voxel location across participants, and possibly the physiological differences across individuals. In patients, the 
variability in SNR and acquisition time improvement was additionally associated with the limited sample size 
of 5. Future studies will benefit from investigations on SNR and acquisition time improvement conducted on 
larger patient cohorts.
Enhanced SNR can be used to improve the accuracy of PUFA quantification, trade for reduced acquisition 
time, or enhance acquisition voxel volume. In comparison to Equal Weighting, AOC reduces acquisition time to 
approximately a quarter (median: 28%, range: 6–43% of original acquisition time) to maintain same output SNR, 
or improves SNR by 61% (34–105%) with same scan duration (equivalent to a reduction of voxel volume to 62% 
or 85% in each dimension). We also compared AOC with S/N2 Weighting as a non-noise decorrelated algorithm 
yielding the highest SNR in our study among the rest of the linear algorithms. In that case, acquisition is 1.5 times 
faster (AOC reduces acquisition time to 68% (56–71%) compared to S/N2 Weighting) to maintain same output 
SNR, or SNR is improved by 24% (4–28%) with same scan duration. These results show that noise correlation in 
breast MRS should be considered to achieve an optimised combination. A fast acquisition would be clinically val-
uable for elderly patients, who might experience difficulties remaining still in prone position or maintaining shal-
low breathing. Furthermore, the enhanced SNR would allow the assessment of small tumours more prevalent in 
breast cancer following the introduction of screening programmes. Reduced scan time would also be valuable for 
PUFA MR spectroscopic imaging (MRSI) when assessment of the whole diseased breast is necessary4. However, 
further analysis should be conducted to evaluate AOC performance on PUFA MRSI.
This study was limited on a single scanner and future work will benefit from multi centre studies on 
larger patient cohorts using scanners from different vendors, magnetic field strength, and breast coils. 
However, we deployed different coils for data collection between ex vivo and in vivo experiments with the 
Figure 2. Comparison of the combination algorithms on experimental PUFA spectra. SNR improvement for 
(a) excised breast tumour specimens, (b) healthy volunteers, and (c) patients. The box plot shows the median 
and interquartile range while the error bar shows the mean and standard deviation of SNR improvement from 
each algorithm. For WSVD, the improvement was negative for 5 data out of 17 for excised breast tumour 
specimens, 2 data out of 30 for healthy volunteers and 2 data out of 5 for patients. Each dot represents an 
individual measurement. For subfigures a and b, overlapping data points are displaced horizontally to aid 
visual interpretation. AOC = adaptively optimised combination. Nd-comb = noise decorrelation combination, 
WSVD = whitened singular value decomposition.
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results demonstrating the applicability of the algorithms under diverse conditions. The tumours studied 
in this work were limited to invasive ductal carcinoma with large size, and future investigation should be 
carried out in smaller tumours and other phenotypes. However, invasive ductal carcinoma accounts for 
approximately 75% breast cancer cases26, and the tumour size in this study is representative of typical patient 
population requiring MR scan.
AOC, among current algorithms, provided the maximum SNR improvement and is robust against low SNR or 
contamination signal. The derived SNR improvement was not dependent on experimental conditions of PUFA, 
water and fat content or voxel volume. Hence AOC is the optimal algorithm for PUFA spectra acquired using 
MQC MRS in breast to improve quantification accuracy, reduce acquisition time and reduce acquisition voxel 
volume.
Figure 3. Spectra from a patient. (a) Combined spectra obtained from the breast tumour of a patient using 
AOC, nd-comb, WSVD, S/N2 Weighting, S/N Weighting, Signal Weighting, and Equal Weighting with SNR 
improvement of 60.9%, 55.8%, −100%, 25.4%, 19.2%, 12.6% respectively. (b) Voxel location (2 × 2 × 2 cm3) 
within an invasive ductal carcinoma, grade III, acquired from a 68-year old patient. AOC = adaptively 
optimised combination. Nd-comb = noise decorrelation combination, WSVD = whitened singular value 
decomposition, ppm = parts per million.
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Methods
Experiments were conducted in freshly excised human breast tumours, healthy female volunteers and patients 
with breast cancer. The ex vivo and in vivo studies were approved by the North West – Greater Manchester East 
Research Ethics Committee (REC reference: 16/NW/0032) and the North of Scotland Research Ethics Service 
(REC reference: 16/NS/0077) respectively. All experiments were conducted in accordance with the Declaration of 
Helsinki guidelines and written informed consent was obtained from all participants prior to the study.
Ex Vivo experiments. 17 female patients (mean age, 61 years; age range, 42–78 years) with invasive ductal 
carcinoma (8 grade II and 9 grade III) and a tumour size greater than 10 mm in diameter were enrolled consecu-
tively from Aberdeen Royal Infirmary hospital between February 2016 and June 2017. Patients having undergone 
chemotherapy or hormonal therapy were not eligible. The whole tumour, freshly excised with wide local excision 
or mastectomy, was placed in a container and immediately scanned, without formalin treatment, on a 3 T clinical 
MRI scanner (Achieva TX, Philips Healthcare, Best, Netherlands) using a body coil for uniform transmission and 
a 32-element phased array receiver coil for signal detection. Whole excised tissues were positioned in the centre 
of receiver coil. PUFA data were acquired using a single voxel MQC PRESS sequence4 with repetition time (TR) 
Figure 4. Spearman’s rank tests between SNR improvement and experimental parameters. The SNR 
improvement derived from AOC was correlated against (a) PUFA content for breast tumour specimens, (b) 
PUFA content for healthy volunteers, (c) voxel volume for breast tumour specimens, and (d) water/fat ratio 
for breast tumour specimens. Each dot represents an individual measurement. Spearman’s rho and p-value are 
displayed. Correlation against voxel volume for healthy volunteers was not conducted since the voxel remained 
constant across the entire cohort. Moreover, since the voxel was positioned in the adipose tissue, water signal 
was not detected. Therefore, correlation between SNR improvement and water/fat ratio was not conducted 
for healthy volunteers. AOC = adaptively optimised combination, PUFA = polyunsaturated fatty acids, 
SNR = signal to noise ratio.
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of 1250 ms, echo time (TE) of 130 ms, 1024 data points, spectral bandwidth of 2000 Hz, spectral editing frequency 
at 2.8 ppm and 256 averages. The scan time of PUFA acquisition was 5 minutes and 25 seconds. Reference spectra 
without water suppression were acquired using single voxel PRESS sequence27 with TR/TE of 1250/144 ms, 1024 
data points, spectral bandwidth of 2000 Hz and 16 averages. The voxel was positioned to cover the whole tumour, 
with a voxel volume ranging from 2.7 to 16.5 cm3 according to tumour size. The noise in each coil element was 
obtained from an acquisition with no radiofrequency pulse applied.
In Vivo experiments. 15 healthy female volunteers (mean age, 66 years; age range, 58–76 years) with no 
history of breast cancer and 5 patients (mean age, 65 years; age range, 59–69 years) with invasive ductal carcinoma 
(3 grade II and 2 grade III) and a tumour size greater than 10 mm were recruited consecutively from North-East 
Scotland and Aberdeen Royal Infirmary respectively between September 2017 and August 2018. Only patients 
without chemotherapy or hormonal therapy were eligible. Spectra were acquired on a 3 T clinical MRI scanner 
(Achieva TX, Philips Healthcare, Best, Netherlands) using a body coil for uniform transmission and a 16-element 
phased array breast receiver coil for signal detection. The participants were in the prone position to minimise the 
effects of respiratory motion without respiratory gating, following standard clinical procedure. PUFA data were 
acquired using a single voxel MQC PRESS sequence4 with repetition time (TR) of 1250 ms, echo time (TE) of 
130 ms, 1024 data points, spectral bandwidth of 2000 Hz, spectral editing frequency at 2.8 ppm and 256 or 128 
averages for patients and volunteers respectively. Reference spectra without water suppression were acquired 
using single voxel PRESS sequence27 with TR/TE of 1250/144 ms, 1024 data points, spectral bandwidth of 2000 
Hz and 16 averages. For volunteers, data were collected from both breasts with a voxel size of 2 × 2 × 2 cm3 con-
taining mainly the adipose tissue. For patients, data were collected from the diseased breast with the voxel cov-
ering the tumour and voxel volume ranging from 2.6 to 8 cm3 according to tumour size. The noise in each coil 
element was obtained from an acquisition with no radiofrequency pulse applied.
Data processing. Data were processed using in house software written in MATLAB (MathWorks, Natick, 
MA, USA), using fully automated literature methods (Table 1). The amplitude and phase shift were determined 
from the dominant peak (either water at 4.7 ppm or lipid at 1.3 ppm) in the reference spectrum. The SNR of each 
combined spectrum was defined as the PUFA peak height divided by the standard deviation of the real part of 
the spectrum within the range of 9.0–10.6 ppm25. The SNR improvement was defined as percentage increase 
of SNR referenced to the SNR derived from the Equal Weighting algorithm (signals are phased and equally 
weighted) as in line with literature9. The SNR derived from the Equal Weighting algorithm was defined as baseline 
SNR. Water (4.7 ppm), methyl fat (0.9 ppm) and methylene fat (1.3 ppm) from the reference spectrum and PUFA 
(5.3 ppm in MQC MRS) were quantified using AMARES algorithm28 in jMRUI software (v5.0, TRANSACT, 
Leuven, Belgium)29. PUFA content was expressed as percentage ratio of PUFA divided by the total lipids in ref-
erence spectrum (sum of methyl and methylene fat). Water to fat ratio was defined as the ratio of water divided 
by the total lipids. For each patient, 256 SNRs were further derived from raw data containing the corresponding 
number of repeated acquisitions using the optimal algorithm (AOC), the non-noise decorrelated algorithm with 
the highest improvement (S/N2 Weighting), and baseline SNR (Equal Weighting). As a result, the first SNR was 
derived from the first acquisition, the nth SNR from the first n spectra, and the 256th SNR from the entire 256 
spectra. The mean SNR for each repeated acquisition was subsequently computed across all the 5 patients. As a 
Figure 5. SNR as a function of the number of repeated acquisitions. The mean SNR obtained using AOC 
and S/N2 Weighting for PUFA spectra acquired from five patients is plotted as a function of the number of 
repeated acquisitions. Baseline SNR is also shown. The dotted line shows the maximum average baseline 
SNR (SNR = 10.4) and maximum average SNR using S/N2 Weighting (SNR = 14.1) after averaging for 256 
acquisitions. To achieve the same SNR using AOC, the acquisition time can be reduced to 28% (6–43%) 
compared to baseline. If noise correlation is not ignored, the acquisition time can be reduced to 68% (46–72%) 
(1.5 times faster) compared to S/N2 Weighting. Values are given as median and range in parenthesis. Standard 
errors for each line are shown in Supplementary Fig. S2a,b.
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result, the scan duration using the optimal algorithm was compared against non-noise decorrelation algorithms 
and baseline when same output SNR is maintained.
statistical analysis. Statistical analysis was performed in SPSS (Release 24.0, SPSS Inc., Chicago, USA). 
Shapiro-Wilk test was performed on the SNR improvement to assess normality. For normally distributed data, 
a repeated measures ANOVA test was performed to assess the group difference between the algorithms while 
Friedman and Wilcoxon signed-rank tests were used for non-normally distributed data. For patient data, with 
small sample size and an assumption of non-normal distribution (following indicatory pattern from breast 
tumour specimens), a Wilcoxon signed-rank test was performed. Data with negative SNR improvement were 
excluded for WSVD (5 out of 17 in breast tumour specimens and 2 out of 30 in healthy volunteers). Spearman’s 
rank tests were further performed to examine the dependency of the SNR improvement, derived from the optimal 
algorithm, on experimental conditions of PUFA content, voxel volume, and water/fat ratio. A p-value < 0.05 was 
considered as statistically significant. All statistical tests were two sided.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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